GLP-1 agonists are often called the miracle drug for diabetes and weight management
However, the genetic associations with l-carnitine and with the outcomes are all from studies in people of European descent, with genomic control
American Journal of Psychiatry , 170 (9), 10321040.
Cardiovascular Benefits Large clinical trials show that certain GLP-1 medications: Reduce major cardiovascular events Improve blood pressure and cholesterol Support overall heart health in high-risk patients This makes them especially valuable for patients with diabetes and cardiovascular risk factors
"We are confident and ready to meet demand so patients can count on timely access to Wegovy pill," Dave Moore, executive vice president of U.S
People who take semaglutide are at an increased risk of medullary thyroid carcinoma (thyroid cancer), acute pancreatitis, gallbladder disease, hypoglycemia (low blood sugar), acute kidney injury, increased heart rate, diabetic retinopathy complications, depression, and suicidal thoughts